SCOPUS 정보 검색 플랫폼

Cell Death and Differentiation

Volumn 13, Issue 6, 2006, Pages 921-926

Strategies for therapeutic targeting of the p53 pathway in cancer

(1) Wiman, Klas G a

a KAROLINSKA INSTITUTE (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; 4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE; ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; CISPLATIN; ELLIPTICINE; FLUOROURACIL; MIRA 1; ONYX 015; PRIMA 1; PROTEIN P53; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CLINICAL TRIAL; DRUG STRUCTURE; HEAD AND NECK CANCER; HUMAN; LUNG NON SMALL CELL CANCER; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WILD TYPE;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; AZA COMPOUNDS; BICYCLO COMPOUNDS, HETEROCYCLIC; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; GENE THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; IMIDAZOLES; MUTATION; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 33646799132 PISSN: 13509047 EISSN: 14765403 Source Type: Journal
DOI: 10.1038/sj.cdd.4401921 Document Type: Note

Times cited : (128)

References (61)

1
- 0036674617
- Vousden KH and Lu X (2002) Nat. Rev. Cancer 2: 594-604.
- (2002) Nat. Rev. Cancer , vol.2 , pp. 594-604
- Vousden, K.H.¹ Lu, X.²

2
- 0036258111
- Olivier M et al. (2002) Hum. Mutat. 19: 607-614.
- (2002) Hum. Mutat. , vol.19 , pp. 607-614
- Olivier, M.¹

3
- 33646781723
- Hainaut P, Wiman KG, (eds) (Dordrecht: Springer)
- McKinney K and Prives C (2005) In 25 Years of p53 Research, Hainaut P, Wiman KG, (eds) (Dordrecht: Springer) pp. 27-51.
- (2005) 25 Years of P53 Research , pp. 27-51
- McKinney, K.¹ Prives, C.²

4
- 0034671945
- Sigal A and Rotter V (2000) Cancer Res. 60: 6788-6793.
- (2000) Cancer Res. , vol.60 , pp. 6788-6793
- Sigal, A.¹ Rotter, V.²

5
- 0033547356
- Asker C, Wiman KG and Selivanova G (1999) Biochim. Biophys. Res. Comm. 265: 1-6.
- (1999) Biochim. Biophys. Res. Comm. , vol.265 , pp. 1-6
- Asker, C.¹ Wiman, K.G.² Selivanova, G.³

6
- 84919594813
- 25 years of p53 Research
- Hainaut P, Wiman KG (eds) (Dordrecht: Springer)
- Olivier M, Hainaut P and Börresen-Dale AL (2005) In 25 years of p53 Research, Hainaut P, Wiman KG (eds) (Dordrecht: Springer) pp. 321-338.
- (2005) , pp. 321-338
- Olivier, M.¹ Hainaut, P.² Börresen-Dale, A.L.³

7
- 0242408746
- Bykov VJN and Wiman KG (2003) Ann. Med. 35: 458-465.
- (2003) Ann Med. , vol.35 , pp. 458-465
- Bykov, V.J.N.¹ Wiman, K.G.²

8
- 0031750168
- Clayman GL et al. (1998) J. Clin. Oncol. 16: 2221-2232.
- (1998) J. Clin. Oncol. , vol.16 , pp. 2221-2232
- Clayman, G.L.¹

9
- 0033526357
- Swisher SG et al. (1999) J. Natl. Cancer Inst. 91: 763-771.
- (1999) J. Natl. Cancer Inst. , vol.91 , pp. 763-771
- Swisher, S.G.¹

10
- 0033950285
- Nemunaitis J et al. (2000) J. Clin. Oncol. 18: 609-622.
- (2000) J. Clin. Oncol. , vol.18 , pp. 609-622
- Nemunaitis, J.¹

11
- 12244298187
- Swisher SG et al. (2003) Clin. Cancer Res. 9: 93-101.
- (2003) Clin. Cancer Res. , vol.9 , pp. 93-101
- Swisher, S.G.¹

12
- 0344188096
- Bischoff JR et al. (1996) Science 274: 373-376.
- (1996) Science , vol.274 , pp. 373-376
- Bischoff, J.R.¹

13
- 0030917202
- Heise C et al. (1997) Nat. Med. 3: 639-645.
- (1997) Nat. Med. , vol.3 , pp. 639-645
- Heise, C.¹

14
- 0031743945
- Rothmann T et al. (1998) J. Virol. 72: 9470-9478.
- (1998) J. Virol. , vol.72 , pp. 9470-9478
- Rothmann, T.¹

15
- 0031798440
- Goodrum FD and Omelles DA (1998) J. Virol. 72: 9479-9490.
- (1998) J. Virol. , vol.72 , pp. 9479-9490
- Goodrum, F.D.¹ Omelles, D.A.²

16
- 0031697770
- Hall AR et al. (1998) Nat. Med. 4: 1068-1072.
- (1998) Nat. Med. , vol.4 , pp. 1068-1072
- Hall, A.R.¹

17
- 0034658418
- Dix BR et al. (2000) Cancer Res. 60: 2666-2672.
- (2000) Cancer Res. , vol.60 , pp. 2666-2672
- Dix, B.R.¹

18
- 0033831080
- Khuri FR et al. (2000) Nat. Med. 6: 879-885.
- (2000) Nat. Med. , vol.6 , pp. 879-885
- Khuri, F.R.¹

19
- 0033693231
- Nemunaitis J et al. (2000) Cancer Res. 60: 6359-6366.
- (2000) Cancer Res. , vol.60 , pp. 6359-6366
- Nemunaitis, J.¹

20
- 0035863458
- Nemunaitis J et al. (2001) J. Clin. Oncol. 19: 289-298.
- (2001) J. Clin. Oncol. , vol.19 , pp. 289-298
- Nemunaitis, J.¹

21
- 0035177690
- Reid T et al. (2001) Gene Therapy 8: 1618-1626.
- (2001) Gene Therapy , vol.8 , pp. 1618-1626
- Reid, T.¹

22
- 0036828125
- Reid T et al. (2002) Cancer Res. 62: 6070-6079.
- (2002) Cancer Res. , vol.62 , pp. 6070-6079
- Reid, T.¹

23
- 0037314610
- Hecht JR et al. (2003) Clin. Cancer Res. 9: 555-561.
- (2003) Clin. Cancer Res. , vol.9 , pp. 555-561
- Hecht, J.R.¹

24
- 22244479672
- O'Shea CC et al. (2005) Cancer Cell 8: 61-74.
- (2005) Cancer Cell , vol.8 , pp. 61-74
- O'Shea, C.C.¹

25
- 0026740449
- Oliner JD et al. (1992) Nature 358: 80-83.
- (1992) Nature , vol.358 , pp. 80-83
- Oliner, J.D.¹

26
- 0033993563
- Sherr CJ and Weber JD (2000) Curr. Opin. Genet. Dev. 10: 94-99.
- (2000) Curr. Opin. Genet. Dev. , vol.10 , pp. 94-99
- Sherr, C.J.¹ Weber, J.D.²

27
- 8844278362
- Bond GL et al. (2004) Cell 119: 591-602.
- (2004) Cell , vol.119 , pp. 591-602
- Bond, G.L.¹

28
- 0037317840
- Chene P (2003) Nat. Rev. Cancer 3: 102-109.
- (2003) Nat. Rev. Cancer , vol.3 , pp. 102-109
- Chene, P.¹

29
- 0030575937
- Kussie PH et al. (1996) Science 274: 948-953.
- (1996) Science , vol.274 , pp. 948-953
- Kussie, P.H.¹

30
- 10744221485
- Vassilev LT et al. (2004) Science 303: 844-848.
- (2004) Science , vol.303 , pp. 844-848
- Vassilev, L.T.¹

31
- 11144315535
- Issaeva N et al. (2004) Nat. Med. 10: 1321-1328.
- (2004) Nat. Med. , vol.10 , pp. 1321-1328
- Issaeva, N.¹

32
- 33244495492
- Yang Y et al. (2005) Cancer Cell 7: 547-559.
- (2005) Cancer Cell , vol.7 , pp. 547-559
- Yang, Y.¹

33
- 20144363317
- Berkson RG et al. (2005) Int. J. Cancer 115: 701-710.
- (2005) Int. J. Cancer , vol.115 , pp. 701-710
- Berkson, R.G.¹

34
- 0035496607
- Bullock AN and Fersht AR (2001) Nat. Rev. Cancer 1: 68-76.
- (2001) Nat. Rev. Cancer , vol.1 , pp. 68-76
- Bullock, A.N.¹ Fersht, A.R.²

35
- 0029124132
- Abarzua P et al. (1995) Cancer Res. 55: 3490-3494.
- (1995) Cancer Res. , vol.55 , pp. 3490-3494
- Abarzua, P.¹

36
- 0030961889
- Selivanova G et al. (1997) Nat. Med. 3: 632-638.
- (1997) Nat. Med. , vol.3 , pp. 632-638
- Selivanova, G.¹

37
- 0032911047
- Selivanova G et al. (1999) Mol. Cell Biol. 19: 3395-3402.
- (1999) Mol. Cell Biol. , vol.19 , pp. 3395-3402
- Selivanova, G.¹

38
- 0033521143
- Kim AL et al. (1999) J. Biol. Chem. 274: 34924-34931.
- (1999) J. Biol. Chem. , vol.274 , pp. 34924-34931
- Kim, A.L.¹

39
- 17644397358
- Li Y et al. (2005) Int. J. Cancer 115: 55-64.
- (2005) Int. J. Cancer , vol.115 , pp. 55-64
- Li, Y.¹

40
- 0345255605
- Issaeva N et al. (2003) Proc. Natl. Acad. Sci. USA 100: 13303-13307.
- (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 13303-13307
- Issaeva, N.¹

41
- 0142058248
- Bykov VJN, Selivanova G and Wiman KG (2003) Eur. J. Cancer 39: 1828-1834.
- (2003) Eur. J. Cancer , vol.39 , pp. 1828-1834
- Bykov, V.J.N.¹ Selivanova, G.² Wiman, K.G.³

42
- 0033601370
- Foster BA et al. (1999) Science 286: 2507-2510.
- (1999) Science , vol.286 , pp. 2507-2510
- Foster, B.A.¹

43
- 0036352592
- Luu Y et al. (2002) Exp. Cell Res. 276: 214-222.
- (2002) Exp. Cell Res. , vol.276 , pp. 214-222
- Luu, Y.¹

44
- 85047687410
- Takimoto R et al. (2002) Cancer Biol. Ther. 1: 47-55.
- (2002) Cancer Biol. Ther. , vol.1 , pp. 47-55
- Takimoto, R.¹

45
- 0344441926
- Wischhusen J et al. (2003) Oncogene 22: 8233-8245.
- (2003) Oncogene , vol.22 , pp. 8233-8245
- Wischhusen, J.¹

46
- 0037370357
- Wang W et al. (2003) Mol. Cell Biol. 23: 2171-2181.
- (2003) Mol. Cell Biol. , vol.23 , pp. 2171-2181
- Wang, W.¹

47
- 0037192628
- Rippin TM et al. (2002) Oncogene 21: 2119-2129.
- (2002) Oncogene , vol.21 , pp. 2119-2129
- Rippin, T.M.¹

48
- 0043170883
- Peng Y et al. (2003) Oncogene 22: 4478-4487.
- (2003) Oncogene , vol.22 , pp. 4478-4487
- Peng, Y.¹

49
- 0035859006
- Maurici D et al. (2001) Oncogene 20: 3533-3540.
- (2001) Oncogene , vol.20 , pp. 3533-3540
- Maurici, D.¹

50
- 0036191959
- North S et al. (2002) Mol. Carcinog. 33: 181-188.
- (2002) Mol. Carcinog. , vol.33 , pp. 181-188
- North, S.¹

51
- 0037378392
- Pluquet O et al. (2003) Biochem. Pharmacol. 65: 1129-1137.
- (2003) Biochem. Pharmacol. , vol.65 , pp. 1129-1137
- Pluquet, O.¹

52
- 0036128899
- Bykov VJ et al. (2002) Nat. Med. 8: 282-288.
- (2002) Nat. Med. , vol.8 , pp. 282-288
- Bykov, V.J.¹

53
- 0036949663
- Bykov VJN et al. (2002) Carcinogenesis 23: 2011-2018.
- (2002) Carcinogenesis , vol.23 , pp. 2011-2018
- Bykov, V.J.N.¹

54
- 19444387176
- Bykov VJN et al. (2005) Oncogene 24: 3484-3491.
- (2005) Oncogene , vol.24 , pp. 3484-3491
- Bykov, V.J.N.¹

55
- 7944235142
- Nahi H et al. (2004) Br. J. Hematol. 127: 285-291.
- (2004) Br. J. Hematol. , vol.127 , pp. 285-291
- Nahi, H.¹

56
- 21344434834
- Li Y et al. (2005) Mol. Cancer Ther. 4: 901-909.
- (2005) Mol. Cancer Ther. , vol.4 , pp. 901-909
- Li, Y.¹

57
- 33644877241
- Rehman A et al. (2005) Breast Cancer Res. 7: R765-R774.
- (2005) Breast Cancer Res. , vol.7
- Rehman, A.¹

58
- 0344925540
- Chipuk JE et al. (2003) Cancer Cell 4: 371-381.
- (2003) Cancer Cell , vol.4 , pp. 371-381
- Chipuk, J.E.¹

59
- 24044466754
- Bykov VJN et al. (2005) J. Biol. Chem. 280: 30384-30391.
- (2005) J. Biol. Chem. , vol.280 , pp. 30384-30391
- Bykov, V.J.N.¹

60
- 0036606407
- Buzek J et al. (2002) Nucleic Acids Res. 30: 2340-2348.
- (2002) Nucleic Acids Res. , vol.30 , pp. 2340-2348
- Buzek, J.¹

61
- 0037195158
- Seo YR, Kelley MR and Smith ML (2002) Proc. Natl. Acad. Sci. USA 99: 14548-14553.
- (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 14548-14553
- Seo, Y.R.¹ Kelley, M.R.² Smith, M.L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.